X

Trial Profile

Clinical trial on the efficacy of the UFT/LV for the Stage II colorectal cancer with risk factors for recurrence

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Folinic acid (Primary) ; Tegafur/uracil (Primary)
Indications Adenocarcinoma; Carcinoma; Colon cancer; Colorectal cancer
Focus Therapeutic Use

Most Recent Events

31 Oct 2023 Results (n=1880) of post hoc analysis of this trial identifying prognostic factors for disease-free survival (DFS) and overall survival published in the International Journal of Colorectal Disease
21 Jan 2023 Final Results presented at the 2023 Gastrointestinal Cancers Symposium
15 Feb 2022 Results published in the BMC Cancer

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com